Literature DB >> 7073216

Use of N-bromosuccinimide for the iodination of proteins for radioimmunoassay.

P Reay.   

Abstract

A new method, employing the mild oxidant N-bromosuccinimide, for the iodination of proteins for radioimmunoassay is described. Human prolactin, follicle-stimulating, luteinising, thyroid-stimulating, and growth hormones were iodinated with 125I by this method to specific activities up to 136 muCi/microgram. Incorporation of iodine ranged from 67% to 83% using 2 microgram hormone, 200 muCi Na125I, 0.5 nmol oxidant, and a reaction time of 15s. In comparative studies in immunological activity after iodination by this method was equal to, or greater than that by the chlorine gas, Iodo-Gen, or chloramine-T methods. The reagent is cheap and stable, and the method permits efficient use of antigen and iodide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7073216     DOI: 10.1177/000456328201900214

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  13 in total

1.  Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice.

Authors:  Winston L Hutchinson; Jeff Herbert; Marina Botto; Mark B Pepys
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

2.  The in-vitro inhibition of rat alloantigen presentation by immunotoxins--implications for allografting.

Authors:  K N Wiley; A Clark; M Fox
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

3.  VP2 is the major exposed protein on orbiviruses.

Authors:  S A Lewis; M J Grubman
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.

Authors:  Simon E Kolstoe; Basil H Ridha; Vittorio Bellotti; Nan Wang; Carol V Robinson; Sebastian J Crutch; Geoffrey Keir; Riitta Kukkastenvehmas; J Ruth Gallimore; Winston L Hutchinson; Philip N Hawkins; Stephen P Wood; Martin N Rossor; Mark B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

5.  Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?

Authors:  M Greaves; C Pickering; G Knight; A J Boulton; J Ball; J D Ward; F E Preston
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

6.  Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

Authors:  M B Pepys; T W Rademacher; S Amatayakul-Chantler; P Williams; G E Noble; W L Hutchinson; P N Hawkins; S R Nelson; J R Gallimore; J Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.

Authors:  J Malamitsi; J Zorzos; A D Varvarigou; S Archimandritis; C Dassiou; D V Skarlos; P Dimitriou; M Likourinas; A Zizi; C Proukakis
Journal:  Eur J Nucl Med       Date:  1995-01

8.  Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.

Authors:  S A Lewis; D O Morgan; M J Grubman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.

Authors:  W L Hutchinson; G E Noble; P N Hawkins; M B Pepys
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

10.  Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.

Authors:  K A Davies; A M Peters; H L Beynon; M J Walport
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.